← Back to Search

Individuals with known or suspected autoimmune diseases for Multiple Sclerosis

N/A
Recruiting
Led By Erin Longbrake
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 5 years
Awards & highlights

Study Summary

The purpose of this study is to ascertain the functional profiles of the immune cells within the gastrointestinal tract and to determine how these cells contribute to autoimmune and neurologic diseases.

Eligible Conditions
  • Multiple Sclerosis
  • Parkinson's Disease
  • REM Sleep Behavior Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Characterization of immune cells from the gastrointestinal mucosa
Secondary outcome measures
Characterize the microbiome at different anatomic sites within the gastrointestinal tract
Evaluate spatial transcriptomics of intestinal tissue

Trial Design

3Treatment groups
Experimental Treatment
Group I: Individuals with neurologic diseasesExperimental Treatment1 Intervention
Group II: Individuals with known or suspected autoimmune diseasesExperimental Treatment1 Intervention
Group III: Healthy IndividualsExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,853 Previous Clinical Trials
2,738,461 Total Patients Enrolled
8 Trials studying Multiple Sclerosis
1,746 Patients Enrolled for Multiple Sclerosis
Erin LongbrakePrincipal InvestigatorYale University
1 Previous Clinical Trials
400 Total Patients Enrolled
1 Trials studying Multiple Sclerosis
400 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Intestinal Immunity in Neurologic Disease
Erin E Longbrake 2022. "Intestinal Immunity in Neurologic Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06329453.
All > New York City
~65 spots leftby Aug 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top